Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (Loss) Income	$ (19,746)	$ (45,542)
Depreciation and amortization	113,244	119,697
Amortization of Inventory Step-up	0	22,676
Noncash lease expense	11,110	10,888
Provision for doubtful accounts	399	(99)
Provision for warranty and returns	7,070	1,483
Stock compensation	18,931	19,854
Loss on disposal of property and equipment	1,019	267
Bond premium amortization	8	211
Debt Issuance Costs amortization	3,404	3,495
Change in fair value of contingent earn-out	3,316	(27,194)
Sparepartsusage	10,056	5,229
Other Noncash Income (Expense)	2,909	(2,807)
Accounts receivable	46,796	(1,090)
Inventories	(76,040)	(100,024)
Prepaid expenses and other assets	2,983	4,710
Increase (Decrease) in Other Operating Assets	(12,698)	(17,323)
Accounts payable	(46,864)	22,149
Accrued liabilities	(104)	(33,509)
Income taxes, including excess tax benefits and deferred income taxes	(26,022)	(45,798)
Net cash provided by operating activities	39,771	(62,727)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(32,489)	(48,039)
Proceeds from sale of asset	1,431	900
Intangible assets additions	(4,651)	(4,440)
Purchases of investment securities	0	(3,397)
Proceeds from sale of investment securities	2,920	26,198
Net cash used in investing activities	(32,789)	(1,872,942)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt, net of lender debt issuance costs	0	1,672,631
Repayments of Long-term Debt	14,813	18,125
Payments of Debt Issuance Costs	0	(1,852)
Proceeds from exercise of stock options	2,233	2,992
Finance Lease, Principal Payments	(436)	(321)
Payment, Tax Withholding, Share-based Payment Arrangement	8,718	10,438
Net cash (used in) provided by financing activities	(21,734)	1,644,887
Effect of Exchange Rate on Cash [Abstract]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	1,855	(6,347)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(12,897)	(297,129)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	195,887	255,698
Supplemental Cash Flow Information [Abstract]
Capital Expenditures Incurred but Not yet Paid	2,362	5,539
NON-CASH INVESTING ACTIVITIES
Payments to Acquire Businesses, Net of Cash Acquired	0	(1,844,164)
SmithsMedical
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (Loss) Income		65,500
Change in fair value of contingent earn-out	$ 3,300
NON-CASH INVESTING ACTIVITIES
Fair Value of Assets Acquired		1,658,692
Net Cash Paid (Received) for current and prior acquisitions		(1,844,164)
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		(575,975)
Business Combination, Liabilities Arising from Contingencies, Amount Recognized		(55,158)
Goodwill, Period Increase (Decrease)		1,437,811
Liabilities Assumed		$ (621,206)